Skip to main content
OpenTrials

Clinical trial condition

Infections, Meningococcal

Explore clinical trials studying Infections, Meningococcal. Study availability and eligibility vary by location and protocol.

65 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Meningococcal trial results

Completed

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults

NCT01165242

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Paramount, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Sacramento, California, United States
View all 32 locations
View Trial Details
Completed

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

NCT00454909

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Daly City, California, United States
  • GSK Investigational Site Fairfield, California, United States
  • GSK Investigational Site Redwood City, California, United States
  • GSK Investigational Site Sacramento, California, United States
View Trial Details
Completed

Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612

NCT00465816

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Aarhus N, Denmark
  • GSK Investigational Site Karlskrona, Sweden
  • GSK Investigational Site Linköping, Sweden
  • GSK Investigational Site Malmö, Sweden
View Trial Details
Completed

Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years

NCT00290329

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Alabang, Muntinlupa City, Philippines
  • GSK Investigational Site Binangonan, Rizal, Philippines
  • GSK Investigational Site Cainta, Rizal, Philippines
  • GSK Investigational Site City of Muntinlupa, Philippines
View Trial Details
Completed

Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old

NCT00196976

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Eferding, Austria
  • GSK Investigational Site Graz, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Vienna, Austria
View all 17 locations
View Trial Details
Completed

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

NCT00427908

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View Trial Details
Completed

Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

NCT00758264

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Mexico City, Mexico
  • GSK Investigational Site México, Mexico
  • GSK Investigational Site Taipei, Taiwan
  • GSK Investigational Site Taipei, Taiwan
View Trial Details

Related conditions